Total planned funding: $40,785,827
Clear active filters
Democratic Republic of the Congo
Treatment
HTXD: Treatment: ARV Drugs
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Democratic Republic of the Congo | $40,785,827 |
Organizational Types
Private Contractor | $40,535,514 |
Own Agency | $224,794 |
NGO | $25,519 |
Multi-lateral Agency | $0 |
University | $0 |
FBO | $0 |
Other USG Agency | $0 |
Program Areas
Treatment | $40,785,827 |
Budget Codes
HTXD: Treatment: ARV Drugs | $40,785,827 |
Top Partner Programs
Chemonics International:
$40,535,514
Countries/Regions
Democratic Republic of the Congo
2016 | $10,635,809 |
2018 | $11,556,778 |
2020 | $18,342,927 |
USG Aggregated Agencies:
$224,794
Countries/Regions
Democratic Republic of the Congo
2016 | $109,546 |
2018 | $115,248 |